Affordable Access

deepdyve-link
Publisher Website

Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.

Authors
  • Oka, Tomonori1
  • Sugaya, Makoto
  • Takahashi, Naomi
  • Nakajima, Rina
  • Otobe, Sayaka
  • Kabasawa, Miyoko
  • Suga, Hiraku
  • Miyagaki, Tomomitsu
  • Asano, Yoshihide
  • Sato, Shinichi
  • 1 Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. , (Japan)
Type
Published Article
Journal
Acta dermato-venereologica
Publication Date
Nov 15, 2017
Volume
97
Issue
10
Pages
1172–1177
Identifiers
DOI: 10.2340/00015555-2723
PMID: 28597022
Source
Medline
License
Unknown

Abstract

Interleukin-19 (IL-19), a pro-inflammatory cytokine known to stimulate the production of T helper type 2 (Th2) cytokines, is induced by IL-17A and highly expressed in the lesional skin of psoriasis and atopic dermatitis (AD). This aim of this study was to investigate whether IL-19 is involved in cutaneous T-cell lym-phoma (CTCL) and AD. IL-19 levels were significantly higher in the sera of patients with AD and those with advanced-stage CTCL than in normal controls, correlating significantly with clinical disease markers. IL-19 mRNA levels in lesional skin of both diseases were significantly elevated. Immunohistochemical staining revealed that IL-19 was expressed in the epidermis of AD skin and CTCL skin. In vitro, IL-17A and IL-4 increased IL-19 mRNA expression in human keratinocytes. Thus, IL-19 was increased in the sera and skin of AD and CTCL. These results suggest that IL-19 is important for bridging Th17 to Th2 in these diseases.

Report this publication

Statistics

Seen <100 times